Evergene and Stagen start jointly into genetic analysis business

Evergene, a 100 % subidiary of e-service provider MIT, and Stagen, a Tokyo-based service provider for clinical tests, have started their genetic analysis business „DearGene“. The focus is on genetic risk prediction of various life-style related diseases, female health management, food allergy and cancer. SNP analysis is handled by Takara Bio

Evergene press release, April 10, 2015

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny